Results of a 1-year randomised double-blind placebo-controlled trial with methotrexate 25 mg/week in recently diagnosed polymyalgia rheumatica
Thomas E. Bolhuis, Noortje E.S.E.P. Kooijman, Diane Marsman, Gijs F. Snijders, Alfons A den Broeder, Nathan den Broeder, Aatke van der Maas
Topics & Concepts
MedicineMethotrexatePolymyalgia rheumaticaRandomized controlled trialInternal medicineClinical trialRheumatoid arthritisSurgeryGiant cell arteritisAntifolateGastroenterologyArthritisPrednisoneAntimetaboliteVasculitis and related conditionsMyeloproliferative Neoplasms: Diagnosis and TreatmentOtitis Media and Relapsing Polychondritis